Merck CEO May Testify in Vioxx Suits
- Share via
From Associated Press
Merck & Co.’s chairman and chief executive, Raymond V. Gilmartin, may testify by March in some of the dozens of lawsuits filed in New Jersey over the pharmaceutical giant’s withdrawal of its blockbuster arthritis drug Vioxx, a lawyer for Merck said.
Scheduling for Gilmartin’s pretrial depositions is still being finalized, but the testimony is expected to be given in March, said Ted Mayer, an attorney for Whitehouse Station, N.J.-based Merck.
Merck shares rose 25 cents to $32.20 on the NYSE.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
